Amylyx Pharmaceuticals (AMLX) Change in Inventory (2022 - 2024)

Amylyx Pharmaceuticals' Change in Inventory history runs 3 years deep, the most recent figure standing at $9.3 million for Q1 2024.

• In Q1 2024, Change in Inventory fell 30.44% year-over-year to $9.3 million; the TTM figure through Dec 2024 stood at $9.3 million (down 87.35% YoY), while the FY2024 annual figure was $9.3 million, down 87.35% from the prior year.
• Change in Inventory was $9.3 million for Q1 2024 at Amylyx Pharmaceuticals, down from $26.5 million in the prior quarter.
• In the past five years, Change in Inventory ranged from a high of $26.5 million in Q4 2023 to a low of $9.2 million in Q4 2022.
• Historically, Change in Inventory has averaged $15.3 million across 3 years, with a median of $13.7 million in 2023.
• The sharpest annual moves came in 2023 and 2024: Change in Inventory jumped 187.65% in 2023, then slumped 30.44% in 2024.
• A 3-year view of Change in Inventory shows it stood at $9.2 million in 2022, then surged by 187.65% to $26.5 million in 2023, then plunged by 65.06% to $9.3 million in 2024.
• The last three Change in Inventory figures came in at $9.3 million (Q1 2024), $26.5 million (Q4 2023), and $14.0 million (Q3 2023), per Business Quant data.